Viz.ai and Qure.ai occupy different positions in radiology AI procurement. Viz.ai describes Viz.ai One as an AI-powered care coordination platform with suites for neuro, cardio, vascular, trauma, and radiology, plus a communication tool called Viz Connect [1][2]. Qure.ai describes products such as qXR, qER, qCT, and qMSK as imaging interpretation and workflow tools, with public API documentation specifying output formats and input criteria [7][10][12]. The comparison is not between two identical platforms. Buyers evaluating this pair should first determine whether the organizational need is enterprise-wide alerting and specialist coordination or a focused imaging AI with defined technical outputs. Regulatory status also differs by product and geography, and several implementation details remain undocumented in the retrieved materials.
Platform Architecture and Intended Organizational Setting
Viz.ai positions Viz.ai One as a single platform for multiple clinical applications. The vendor states that the solution is designed to help ensure patients receive lifelong care and treatments when and where needed [1]. The platform includes Viz Neuro, Viz Cardio, Viz Vascular, Viz Trauma, and Viz Radiology suites, each described as tailored to a therapeutic area [1][2]. Viz Connect is presented as a proprietary communication and workflow tool that unites multidisciplinary specialists and care teams across therapeutic areas, from stroke neurology to cardiology [1]. This architecture implies a health system or integrated delivery network setting where multiple service lines share a common alerting and communication layer.
Qure.ai's documented structure is product-specific rather than a unified suite. The company lists separate products for chest X-ray reporting, TB care cascades, lung nodule management, stroke and TBI, MSK X-ray reporting, and heart failure [7]. The US site describes an end-to-end approach for early lung nodule care, supporting radiologists, pulmonologists, and emergency physicians across the lung nodule pathway [8]. The intended setting appears to be radiology departments, teleradiology groups, and screening programs where a specific imaging modality or disease pathway drives the purchase. Qure.ai does not document a cross-specialty care coordination layer equivalent to Viz Connect in the retrieved sources.
Edition and Module Scope
Viz.ai's scope is documented through named suites and a Microsoft collaboration. A one-pager describes a combined suite of 50+ AI models across oncology, cardiovascular, gastrointestinal, orthopedic, spine, emergency, and neurosciences [3][4]. Specific algorithms listed include Viz LVO, Viz CTP, Viz ICH, Viz Aneurysm, Viz SDH, Viz PE, Viz Aortic, and Viz AAA, among others [4]. The vendor also describes Viz Orchestrator, which automatically routes the right algorithm on the right image at the right time [6]. This breadth suggests that Viz.ai One is sold as an enterprise platform where additional algorithms and suites can be activated within a common infrastructure.
Qure.ai's module scope is narrower and more explicitly tied to individual regulatory clearances. The US site lists qXR-LN for lung nodule localization as FDA cleared for radiologists, pulmonologists, and emergency physicians reviewing adult chest imaging, and qCT LN Quant as FDA cleared for radiologists and pulmonologists [8]. The regulatory page describes qER as FDA 510(k) cleared for workflow triage by flagging intracranial hemorrhage, mass effect, midline shift, and cranial fracture in head CT images [9]. qCT-quant is described as FDA cleared for automated analysis of user-selected regions within lung CT [9]. Buyers should verify which specific Qure.ai product and version carries the clearance relevant to their intended use.
A Suggested Evaluation Workflow for Procurement Teams
A procurement team could structure a two-week evaluation around documented capabilities. Week one would map the organization's highest-volume imaging pathways and identify whether cross-specialty alerting is required. If the need is stroke, trauma, and cardiology coordination across a health system, request a Viz.ai One demonstration focused on Viz Connect and the relevant suites [1][2]. If the need is chest X-ray reporting volume or lung nodule follow-up, request a qXR or qCT demonstration with attention to the API output specifications and input criteria [10][12]. Week two would compare regulatory documentation, asking each vendor for product-specific FDA clearance letters and CE certificates relevant to the intended use [8][9]. This suggestion is a planning aid, not a validated evaluation protocol.
Technical Documentation and Integration Boundaries
Viz.ai's technical documentation emphasizes integration with existing hospital systems. The vendor states that Viz.ai One integrates with EHR and PACS solutions and supports standard communication protocols such as DICOM, HL7, and FHIR [5][6]. The platform page lists vendor-agnostic HL7 and FHIR integrations, with integrations for Epic, Cerner, Meditech, and others available [6]. Viz.ai also describes a partnership with Redox for secure integrations [6]. The radiology page states that the solution can send algorithm-processed images back to PACS for consistency and provide contextual linking to the Viz solution [2]. These statements describe integration capabilities but do not document specific configuration requirements or limitations.
Qure.ai provides public API documentation that specifies output formats and input criteria. The qXR output specification lists GSPS overlays, PDF reports, DICOM encapsulated reports, structured reports, and secondary capture files [10]. The platform API documentation states that generated outputs are available as a response payload with URLs for file downloads [11]. The qXR get-started page specifies acceptance criteria including PA/AP view, minimum resolution of 1440 by 1440, patient age over six years, erect or supine position, modalities CR/DR/DX/RF, valid DICOM format, and chest body part [12]. This level of technical specificity is not present in the retrieved Viz.ai materials, which focus on workflow and integration rather than algorithm input parameters.
Regulatory Status and Geographic Boundaries
Viz.ai's regulatory documentation in the retrieved sources is less explicit. The Microsoft one-pager lists GDPR compliance, AWS Well-Architected, CSA certification, ISO certification, NIST compliance, and SOC 2 Type II certification [3][4]. The brochure mentions US and EU presence and states that some listed capabilities are in development or pending clearance [5]. The platform page cites 99.11% sensitivity and 99.3% specificity for Viz Orchestrator, but does not specify the clinical indication or regulatory clearance associated with that performance figure [6]. Buyers should request product-specific FDA clearance documentation from Viz.ai rather than inferring regulatory status from platform-level marketing.
Qure.ai's regulatory page provides more granular detail. The company states that qXRv3.1 and qERv2.0 EU products have Class IIa CE certification under EU MDD, while qXRv4.0, qER-NCCT, qCT, and qMSK have Class IIb CE certification under EU MDR [9]. Qure.ai holds MDSAP certification for ISO 13485:2016 from TUV SUD [9]. The company also lists ISO/IEC 27001 certification and describes cybersecurity audit reports as part of FDA submissions and CE technical files [9]. The US site notes that reimbursement for AI-enabled lung cancer and neurocritical care pathways is evolving, with products billable under CMS-issued CPT codes such as 0721T and 0727T [8]. Qure.ai advises consulting local medical-necessity and documentation policies before billing [8].
Customer Segment Differences and Unresolved Questions
The documented customer segments differ. Viz.ai states that it is trusted by 1,800 hospitals on one page and more than 1,400 hospitals on another, with adoption by a majority of the top 50 IDNs and more than 35,000 providers [1][5][6]. The vendor describes turnkey implementation with no on-prem hardware or maintenance required and a dedicated 24/7 on-call Customer Success team [6]. This positioning targets large health systems and integrated delivery networks seeking a single AI vendor across multiple service lines. Qure.ai's qXR page states 90+ countries and 3,100+ sites, with use cases including teleradiology and immigration screenings [7]. The US site features quotes from vRad, University Hospitals Cleveland Medical Center, and Sinai Chicago [8]. This suggests a mix of high-volume radiology groups, academic centers, and global screening programs.
Several questions remain unresolved from the retrieved documentation. Neither vendor provides a complete list of FDA-cleared algorithms with corresponding 510(k) numbers in the cited materials. Viz.ai's claim of 50+ FDA-cleared algorithms appears in a Microsoft one-pager but is not itemized [3]. Qure.ai's US regulatory status is documented for specific products, but the global marketing pages describe capabilities that may not carry US clearance. Integration depth with specific EHR versions, data residency options, and pricing are not documented. Buyers should request product-specific regulatory summaries, reference customers in similar care settings, and technical validation against their own PACS and EHR configurations before shortlisting either vendor.
Sources & references
- Viz.ai® One | AI-Powered Care Coordination · www.viz.ai
- Viz™ Radiology | AI-Powered Care Coordination · www.viz.ai
- Viz.ai One® & Microsoft Cloud for Healthcare · www.viz.ai
- Viz.ai OneTM & Microsoft Cloud for Healthcare · www.viz.ai
- This is the face of better outcomes. - Viz.ai · www.viz.ai
- Scalable Enterprise Platform, Trusted by Leading Health Systems - Viz.ai, the Proven AI-Powered Care Coordination Platform · www.viz.ai
- qXR AI enabled comprehensive Chest X-ray reporting tool · www.qure.ai
- AI Healthcare Solutions in USA - Qure.ai · www.qure.ai
- Qure AI | We ensure that our products are safe · www.qure.ai
- qXR · documentation.qure.ai
- Output Specifications · documentation.qure.ai
- qXR · documentation.qure.ai